Newly Formed European Thrombosis & Haemostasis Alliance Calls for Patient Safety & Research Strategy

March 27, 2018

The European Thrombosis and Haemostasis Alliance (ETHA) has been recently formed to advocate for better awareness and prioritisation of thrombosis and haemostasis in European Union (EU) patient safety and research programmes.

ETHA, with its 21 national thrombosis and haemostasis society members, has a united focus on better addressing thrombosis, also known as clotting, and improving the understanding of haemostasis. ETHA stands to work with the public and decision-makers to share expertise in clotting and bleeding disorders, elevate patient-centric policies and promote improved outcomes in the EU. As an initial area of priority, ETHA is highlighting the urgent need to better understand the condition of thrombosis.

Read the full press release here.

Related Campaign News

  • World Thrombosis Day campaign appoints international experts to its Steering Committee highlighting commitment to global diversity

    CHAPEL HILL, NC, USA, November 29, 2023 — World Thrombosis Day, [...]

  • World Thrombosis Day encourages public to “Move Against Thrombosis” to celebrate 10 years of raising awareness worldwide

    CHAPEL HILL, NC, USA, (October 13, 2023) — Today is World Thrombosis [...]

  • Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day

    CHAPEL HILL, NC, USA, (October 12, 2023) — A global survey [...]